NASDAQ:CNTG

Centogene N.V. Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Diagnostics & Research

$0.410

+0.0001 (+0.0244%)

At Close: Jul 02, 2024

Centogene N.V. Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 CNTG shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About Centogene N.V.

Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository, which includes epidemiologic, phenotypic, and heterogen... CNTG Profile

Golden Star

Ticker	Date	Change	Price
RDN	Jun 28	1.45%	$31.10
LNT	Jun 28	0.393%	$50.90
PDBC	Jun 28	1.21%	$14.05
SLM	Jun 28	0.481%	$20.79
TXN	Jun 28	2.00%	$194.53
TRMB	Jun 28	0.536%	$55.92
VIGI	Jun 28	0.185%	$81.28
GFS	Jun 28	0.554%	$50.56
SF	Jun 27	3.42%	$80.65
PRK	Jun 27	4.48%	$137.14

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In